Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct:42:65-70.
doi: 10.1016/j.coi.2016.05.015. Epub 2016 Jun 9.

Challenges and strategies for the eradication of the HIV reservoir

Affiliations
Review

Challenges and strategies for the eradication of the HIV reservoir

Jason T Kimata et al. Curr Opin Immunol. 2016 Oct.

Abstract

Despite the success of highly active antiretroviral therapy (HAART) for inhibiting HIV replication and improving clinical outcomes, it fails to cure infection due to the existence of a stable latent proviral reservoir in memory CD4+ T cells. Because of the longevity of these cells harboring transcriptionally silent proviruses, devising strategies to induce viral gene expression so the host immune response can mediate clearance of the infected cells or the cells can undergo virus-induced cell death, has been of considerable recent interest. Here, we review current knowledge of latency, and the challenges to virus induction and eradication. Novel strategies to reactivate HIV reservoirs more effectively, in combination with immunotherapy, could lead to better clearance of the latent HIV reservoir.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential strategy for eradicating latently infected memory CD4+ T cells. Although antiretroviral therapy (ART) effectively controls HIV replication, the virus persists as a latently integrated proviral form in resting memory CD4+ T cells. As latency is an efficient immune evasion mechanism, it is of significant interest to devise ways to reactive virus expression in order for infected cells to be recognized by the host immune response and cleared, or for the cells to undergo virus-mediated cell death. However, neither process appears to readily occur following treatment with latency reversing agents. HIV cure strategies should therefore consider approaches to increase these activities. First, immune-mediated clearance of the latently infected CD4+ T cells after reactivation of virus expression could be enhanced by adoptive T cell transfer of broadly specific anti-HIV CTLs and passive immunotherapy with broadly neutralizing antibodies (bNAbs). Second, virus-induced cell killing may be enhanced by sensitizing the cells with small molecule drugs targeting cell survival pathways.

Similar articles

Cited by

References

    1. Ruelas DS, Greene WC. An integrated overview of HIV-1 latency. Cell. 2013;155:519–529. - PMC - PubMed
    1. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol. 2009;7:798–812. - PubMed
    1. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323:1304–1307. - PubMed
    1. Deeks SG. HIV: Shock and kill. Nature. 2012;487:439–440. - PubMed
    1. Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, Lai J, Blankson JN, Siliciano JD, Siliciano RF. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013;155:540–551. - PMC - PubMed

Publication types